Vinayak K. Prasad - Malignant : How Bad Policy and Bad Evidence Harm P

Vinayak K. Prasad - Malignant : How Bad Policy and Bad Evidence Harm P

Regular price £28.39 GBP
Regular price Sale price £28.39 GBP
Sale Sold out
Tax included.

Low stock: 5 left

Free Shipping

Title
Gender
New Store Stock
About this Item

The item is a book Hardback
The Author Name is Vinayak K. Prasad
The Title is Malignant : How Bad Policy and Bad Evidence Harm People with Cancer

Condition New

Other Comments
New Store Stock
Category - Medical


Product Description -
Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel-but what is often missing from the popular narrative is that, far too often, these new drugs have marginal or minimal benefits. Some are even harmful. In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced. Throughout this work, Prasad illuminates deceptive practices which* promote novel cancer therapies long before credible data are available to support such treatment and* exaggerate the potential benefits of new therapies, many of which cost thousands and in some cases hundreds of thousands of dollars. Prasad then critiques the financial conflicts of interest that pervade the oncology field, the pharmaceutical industry, and the US Food and Drug administration. This is a book about how the actions of human beings-our policies, our standards of evidence, and our drug regulation-incentivize the pursuit of marginal or unproven therapies at lofty and unsustainable prices. Prasad takes us through how cancer trials are conducted, how drugs come to market, and how pricing decisions are made, asking how we can ensure that more cancer drugs deliver both greater benefit and a lower price. Ultimately, Prasad says, * more cancer clinical trials should measure outcomes that actually matter to people with cancer * patients on those trials should look more like actual global citizens * we need drug regulators to raise, not perpetually lower, the bar for approval and* we need unbiased patient advocates and experts. This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer-and how we can avoid repeating the policy and practice mistakes of the past.

When possible we will add details of the items we are selling to help buyers know what is included in the item for sale. The details are provided automatically from our central master database and can sometimes be wrong.

Books are released in many editions and variations, such as standard edition, re-issue, not for sale, promotional, special edition, limited edition, and many other editions and versions.  The Book you receive could be any of these editions or variations. If you are looking for a specific edition or version please contact us to verify what we are selling.

 

Gift Ideas
This is a great gift idea.

 

Hours of Service
We have many warehouses, some of the warehouses process orders seven days a week, but the Administration Support Staff are located at a head office location, outside of the warehouses, and typically work only Monday to Friday.


Location ID 245z

iHaveit SKU ID 174067069

SKU: SKU:174067069

Materials

Dimensions

Care Instructions

Shipping & Returns

View full details

Free Shipping

We provide free shipping for all products within the UK